Coronavirus Update: Covaxin gets approval for trials on 2-18 year-olds

Zee News May 12, 2021, 11:02 AM IST,

Bharat Biotech's Covaxin gets approval for next phase of trials on 2-18 year-olds.

ZEENEWS TRENDING STORIES

By continuing to use the site, you agree to the use of cookies. You can find out more by Tapping this link